The master service agreement allows us to keep ALL rights to Lympro and still make revenue during the CLIA phase. It will be better in the long run and got the ball rolling prior to the bridge study being completed.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links